deferasirox msn 360 mg tabletki powlekane
vivanta generics s.r.o. - deferasiroxum - tabletki powlekane - 360 mg
xenleta
nabriva therapeutics ireland dac - lefamulin acetate - pneumonia, bacterial; community-acquired infections - Środki antybakteryjne do stosowania systemowego, - xenleta is indicated for the treatment of community-acquired pneumonia (cap) in adults when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of cap or when these have failed. należy uwzględnić oficjalne zalecenia dotyczące właściwego stosowania antybiotyków agentów.
tukysa
seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - Środki przeciwnowotworowe - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.
retsevmo
eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - Środki przeciwnowotworowe - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.
jaypirca
eli lilly nederland b.v. - pirtobrutinib - chłoniak, mantle-cell - inhibitory białka kinazy - treatment of mantle cell lymphoma (mcl).
metformax 500 500 mg tabletki
teva pharmaceuticals polska sp. z o.o. - metformini hydrochloridum - tabletki - 500 mg
metformax 850 850 mg tabletki
teva pharmaceuticals polska sp. z o.o. - metformini hydrochloridum - tabletki - 850 mg
metformin galena 500 mg tabletki
farmaceutyczna spółdzielnia pracy galena - metformini hydrochloridum - tabletki - 500 mg
metformin galena 850 mg tabletki
farmaceutyczna spółdzielnia pracy galena - metformini hydrochloridum - tabletki - 850 mg
qinlock
deciphera pharmaceuticals (netherlands) b.v. - ripretinib - guzy stromal żołądkowo-jelitowe - Środki przeciwnowotworowe - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.